RVX-208
Apabetalone (RVX-000222) is a selective BET bromodomain inhibitor investigated for cardiovascular and metabolic diseases. Research demonstrates its potential in preclinical models of atherosclerosis and diabetes, showing modulation of key inflammatory and fibrotic pathways in both in vitro and in vivo studies.
Product Specifications
CAS Number
1044870-39-4
Product Name Alternative
RVX 000222, RVX 208, RVX000222, RVX-000222, RVX208, RVX-208, BD2, Apabetalone, EpigeneticReaderDomain, Epigenetic Reader Domain, HIVProtease, HIV, HIV Protease, Human immunodeficiency virus, inhibit, Inhibitor
Field of Research
Epigenetics & Chromatin
Purity
>98%
Bioactivity
BET bromodomain inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 75 mg/ml) or in Ethanol (up to 4 mg/ml) .
Smiles
COc1cc (OC) c2c (c1) [nH]c (nc2=O) -c1cc (C) c (OCCO) c (C) c1
Molecular Formula
C20H22N2O5
Molecular Weight
370.41
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
2-[4- (2-hydroxyethoxy) -3,5-dimethylphenyl]-5,7-dimethoxy-4 (3H) -quinzolinone
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
035531-ML490 100 µL
FBLN1, CT (FBLN1, Fibulin-1) (MaxLight 490) discontinued
Sign In for Pricing
View Details